ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Ophthalmology

Top Ophthalmology Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BARBARA MARSH MD

Ophthalmology

8,176

$730K

1198
1115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

72%
prescriptions for brand name drugs

Avg: 63%

$89
Average prescription price

Avg: $70

FRANK MARES M.D.

Ophthalmology

7,589

$613K

1106
1020 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

64%
prescriptions for brand name drugs

Avg: 63%

$81
Average prescription price

Avg: $70

ARTHUR WEINSTEIN M.D.

Ophthalmology

5,486

$337K

1483
1363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 63%

$61
Average prescription price

Avg: $70

MICHAEL DIMONACO D.O.

Ophthalmology

3,562

$348K

703
655 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

78%
prescriptions for brand name drugs

Avg: 63%

$98
Average prescription price

Avg: $70

KRISTIN REIDY D.O.

Ophthalmology

3,061

$185K

676
601 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 63%

$61
Average prescription price

Avg: $70

ROBERT MELENDEZ M.D.

Ophthalmology

3,002

$254K

722
658 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

77%
prescriptions for brand name drugs

Avg: 63%

$85
Average prescription price

Avg: $70

PAUL GULBAS MD

Ophthalmology

2,969

$234K

800
725 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

61%
prescriptions for brand name drugs

Avg: 63%

$79
Average prescription price

Avg: $70

TINA WATTERBERG M.D.

Ophthalmology

2,864

$189K

848
793 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

83%
prescriptions for brand name drugs

Avg: 63%

$66
Average prescription price

Avg: $70

ROBERT VILLALOBOS MD

Ophthalmology

2,863

$183K

740
672 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

59%
prescriptions for brand name drugs

Avg: 63%

$64
Average prescription price

Avg: $70

MOLLY RITSEMA MD

Ophthalmology

2,561

$179K

610
543 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

69%
prescriptions for brand name drugs

Avg: 63%

$70
Average prescription price

Avg: $70

MARK LESHER M.D.

Ophthalmology

2,500

$150K

781
707 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 63%

$60
Average prescription price

Avg: $70

KENNETH HIMMEL MD

Ophthalmology

2,456

$156K

484
406 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 63%

$64
Average prescription price

Avg: $70

RENNY LEVY M.D.

Ophthalmology

2,271

$117K

597
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

65%
prescriptions for brand name drugs

Avg: 63%

$52
Average prescription price

Avg: $70

PAUL ENGSTROM M.D.

Ophthalmology

2,228

$56.7K

570
517 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 63%

$25
Average prescription price

Avg: $70

CURTIS CORNELIUS MD

Ophthalmology

2,124

$97.1K

508
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

58%
prescriptions for brand name drugs

Avg: 63%

$46
Average prescription price

Avg: $70

ROBERT AVERY MD

Ophthalmology

1,991

$89.9K

311
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 63%

$45
Average prescription price

Avg: $70

SCOTT ALLEN MD

Ophthalmology

1,978

$111K

404
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 63%

$56
Average prescription price

Avg: $70

CHARLES CHIANG M.D.

Ophthalmology

1,924

$88.8K

363
327 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 63%

$46
Average prescription price

Avg: $70

RICHARD LAZARO MD

Ophthalmology

1,881

$137K

435
394 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

66%
prescriptions for brand name drugs

Avg: 63%

$73
Average prescription price

Avg: $70

EDWARD HERNANDEZ M.D.

Ophthalmology

1,823

$184K

453
411 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

85%
prescriptions for brand name drugs

Avg: 63%

$101
Average prescription price

Avg: $70

CHRISTOPHER DEPALO D.O.

Ophthalmology

1,732

$179K

360
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

76%
prescriptions for brand name drugs

Avg: 63%

$103
Average prescription price

Avg: $70

STEWART HAZEL

Ophthalmology

1,685

$153K

257
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

75%
prescriptions for brand name drugs

Avg: 63%

$91
Average prescription price

Avg: $70

DUANE WIGGINS M.D.

Ophthalmology

1,607

$107K

411
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

72%
prescriptions for brand name drugs

Avg: 63%

$67
Average prescription price

Avg: $70

RICHARD SIDD MD

Ophthalmology

1,560

$101K

276
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 63%

$65
Average prescription price

Avg: $70

ROBERT ROTHBERG MD

Ophthalmology

1,520

$102K

422
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

79%
prescriptions for brand name drugs

Avg: 63%

$67
Average prescription price

Avg: $70

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank